本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

9.67
0.0000
成交量:31.26萬
成交額:300.32萬
市值:1.77億
市盈率:-0.54
高:9.82
開:9.70
低:9.40
收:9.67
52周最高:10.38
52周最低:3.51
股本:1,831.03萬
流通股本:1,600.05萬
量比:0.22
換手率:1.95%
股息:- -
股息率:- -
每股收益(TTM):-17.9300
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-41.56%
市淨率:-0.60
市盈率(LYR):-0.54

資料載入中...

公司資料

公司名字:
Karyopharm Therapeutics Inc.
交易所:
NASDAQ
成立時間:
2008
員工人數:
228
公司地址:
85 Wells Avenue,2nd Floor, Suite 210,Newton,Massachusetts,United States
郵編:
02459-3298
電話:
傳真:
- -
簡介:
Karyopharm Therapeutics Inc.於2008年12月22日在特拉華州註冊成立。該公司是一家臨床階段的製藥公司,專註於發現和開發針對核轉運靶點的新型一線藥物,用於治療癌症和重大疾病。該公司的科學專長集中在了解細胞核和細胞質之間細胞內運輸的調節。

董事

名稱
職位
Richard Paulson
President and Chief Executive Officer and Director
Barry E. Greene
Director
Chen Schor
Director
Christy J. Oliger
Director
Deepa R. Pakianathan
Director
Garen G. Bohlin
Director
Zhen Su
Director

股東

名稱
職位
Richard Paulson
President and Chief Executive Officer and Director
Lori Macomber
Executive Vice President, Chief Financial Officer and Treasurer
Michael Mano
Senior Vice President, General Counsel and Secretary
Reshma Rangwala
Executive Vice President, Chief Medical Officer
Sohanya Cheng
Executive Vice President, Chief Commercial Officer
Stuart Poulton
Executive Vice President, Chief Development Officer